EUVIMEDEUVIMED entdecken
Crossref

Network pharmacology-based investigation and in vitro validation of the endothelial protective mechanisms of GZFLW against cerebral ischemia/reperfusion injury

Fengjuan Ou, Yang Qiu, Shangzhen Yu, Yan Huang

Brain Research · 2026-10 · 1888 · 150419

DOI: 10.1016/j.brainres.2026.150419 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain Research, 2026-10. Verfasst von Fengjuan Ou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510120, China; Department of N…. Hauptthemen laut MEDLINE: Reperfusion Injury, Endothelial Cells, Brain Ischemia, Neuroprotective Agents. Die Arbeit nennt 34 Literaturangaben. Gefördert von: Jiangmen Science and Technology Bureau.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To investigate the protective effects and potential mechanisms of Guizhi-Fuling Wan (GZFLW) against cerebral ischemia/reperfusion injury (CIRI). METHODS: Active compounds and predicted targets of GZFLW were identified from TCMSP and BATMAN-TCM, while CIRI-related targets were obtained from GeneCards. Overlapping targets were analyzed using protein-protein interaction (PPI) network and GO/KEGG enrichment analyses. Molecular docking was applied to assess binding between key compounds and core targets. An oxygen-glucose deprivation/reoxygenation (OGD/R) model was established in rat brain microvascular endothelial cells (BMECs). Cell viability, apoptosis, transendothelial electrical resistance (TEER), and FITC-Dextran permeability were assessed. Western blotting was used to examine proteins related to PI3K/AKT signaling, apoptosis regulation, and blood-brain barrier (BBB)-associated tight junction integrity. RESULTS: A total of 43 active compounds and 108 shared targets related to GZFLW and CIRI were identified. Network analysis highlighted AKT1, BCL-2, TNF, IL6, IL1B, TP53, CASP3, and ESR1 as key targets. Major compounds such as quercetin, β-sitosterol, kaempferol, and hederagenin showed strong predicted binding to core targets. In the OGD/R model, GZFLW-containing serum improved BMEC viability, suppressed apoptosis, enhanced TEER, and reduced FITC-Dextran permeability. It also activated PI3K/AKT signaling, upregulated BCL-2 and Claudin-5, and downregulated Bax and p-FOXO1/FOXO1. The PI3K inhibitor LY294002 partially reversed these protective effects. CONCLUSION: GZFLW alleviated OGD/R-induced BMEC injury and improved endothelial barrier integrity, possibly through modulation of PI3K/AKT signaling, the BCL-2/Bax apoptotic pathway, and the FOXO1/Claudin-5 pathway, providing evidence for its therapeutic potential against CIRI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reperfusion InjuryEndothelial CellsBrain IschemiaNeuroprotective AgentsDrugs, Chinese HerbalAnimalsRatsNetwork PharmacologyApoptosisBlood-Brain BarrierSignal TransductionProto-Oncogene Proteins c-aktMolecular Docking SimulationPhosphatidylinositol 3-KinasesCell SurvivalRats, Sprague-DawleyGlucoseProtein Interaction Maps

Stichwörter der Autor:innen

BCL-2/BaxBlood–brain barrierBrain microvascular endothelial cellsCerebral ischemia/reperfusion injuryGuizhi-Fuling WanNetwork pharmacologyPI3K/AKT signaling

Substanzen

Neuroprotective AgentsProto-Oncogene Proteins c-aktDrugs, Chinese HerbalPhosphatidylinositol 3-KinasesGlucose

Autor:innen und Institutionen

  • Department of Neurology, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510120, China; Department of Neurology, Jiangmen Hospital of Traditional Chinese Medicine Affliated…
  • Operation Management Department, Jiangmen Hospital of Traditional Chinese Medicine Affiliated to Jinan University, Jiangmen 529000, China.
  • Department of Neurology, Jiangmen Hospital of Traditional Chinese Medicine Affliated to Jinan University, Jiangmen 529000, China.
  • Department of Neurology, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510120, China. Electronic address: yanhuang2003@126.com.

Förderung

  • Jiangmen Science and Technology Bureau

Zitieren

APA

Ou, F., Qiu, Y., Yu, S., & Huang, Y. (2026). Network pharmacology-based investigation and in vitro validation of the endothelial protective mechanisms of GZFLW against cerebral ischemia/reperfusion injury. Brain Research, 1888, 150419. https://doi.org/10.1016/j.brainres.2026.150419

Vancouver

Ou F, Qiu Y, Yu S, Huang Y. Network pharmacology-based investigation and in vitro validation of the endothelial protective mechanisms of GZFLW against cerebral ischemia/reperfusion injury. Brain Research. 2026;1888:150419. doi:10.1016/j.brainres.2026.150419

BibTeX
@article{Ou2026,
  author = {Ou, Fengjuan and Qiu, Yang and Yu, Shangzhen and Huang, Yan},
  title = {Network pharmacology-based investigation and in vitro validation of the endothelial protective mechanisms of GZFLW against cerebral ischemia/reperfusion injury},
  journal = {Brain Research},
  year = {2026},
  volume = {1888},
  pages = {150419},
  doi = {10.1016/j.brainres.2026.150419}
}
Kostenlos starten →